• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KI-67/MIB-1 标记指数和辛普森分级系统对预测 WHO 分级 I 颅内脑膜瘤与 WHO 分级 II 相比的复发价值。

Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.

机构信息

Neurosurgery Department. Hospital Universitario y Politécnico La Fe, Valencia, Spain; Nanomedicine and Sensors Unit, Hospital Universitario y Politécnico La Fe, Universidad Politécnica de Valencia, Spain.

Pathology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

出版信息

J Clin Neurosci. 2021 Apr;86:32-37. doi: 10.1016/j.jocn.2021.01.009. Epub 2021 Jan 26.

DOI:10.1016/j.jocn.2021.01.009
PMID:33775343
Abstract

Simpson grading of resection has been used as a predictor of intracranial meningioma (IM) recurrence. Histopathological findings, like the Ki-67/MIB-1 labeling index, may be useful in the assessment risk of recurrence. Our objective was to analyze the predictive value of meningioma recurrence using both parameters. We retrospectively studied 322 consecutive patients with histopathological diagnosis of IM WHO grade I and 43 patients with IM WHO grade II in a 13-year period. Multivariate survival analysis was performed. In the WHO grade I IM group, recurrence was observed in 28 patients (8.69%). The Cox regression model for WHO grade I IM, provided a significative hazard ratio (HR) for Ki-67/MIB-1 index ≥3 (HR = 36.35, p < 0.001) and Simpson's grading resection, grade II (HR = 2.03, p = 0.045), grade III (HR = 3.41, p = 0.034) and grade IV (HR = 19.75, p ≥ 0.001). In the WHO grade II IM group, recurrence was observed in 10 patients (23.25%). The Cox regression model for WHO grade II IM, provided a significative hazard ratio (HR) for Ki-67/MIB-1 index ≥3% (HR = 1.66, p < 0.001) and Simpson's grading resection grade III (HR = 3.96, p = 0.027). The Kaplan-Meier survival curve showed a similar distribution of survival between WHO grade I IM with Ki-67/MIB-1 ≥3% and WHO grade II IM. In WHO grade I meningiomas, the Ki-67/MIB-1 index and Simpson grading were both independent predictors of recurrence. A similar management protocol should be advisable for WHO grade I with Ki-67/MIB-1 ≥3% and WHO grade II meningiomas.

摘要

辛普森分级已被用作颅内脑膜瘤 (IM) 复发的预测指标。组织病理学发现,如 Ki-67/MIB-1 标记指数,可能有助于评估复发风险。我们的目的是分析使用这两个参数预测脑膜瘤复发的价值。我们对 13 年间连续收治的 322 例组织学诊断为 I 级脑膜瘤和 43 例 II 级脑膜瘤的患者进行了回顾性研究。进行了多变量生存分析。在 I 级脑膜瘤组中,28 例(8.69%)患者出现复发。I 级脑膜瘤的 Cox 回归模型为 Ki-67/MIB-1 指数≥3(HR=36.35,p<0.001)和辛普森分级切除,II 级(HR=2.03,p=0.045),III 级(HR=3.41,p=0.034)和 IV 级(HR=19.75,p≥0.001)提供了有意义的危险比(HR)。在 II 级脑膜瘤组中,10 例(23.25%)患者出现复发。II 级脑膜瘤的 Cox 回归模型为 Ki-67/MIB-1 指数≥3%(HR=1.66,p<0.001)和辛普森分级切除 III 级(HR=3.96,p=0.027)提供了有意义的危险比(HR)。Kaplan-Meier 生存曲线显示,Ki-67/MIB-1≥3%的 I 级脑膜瘤和 II 级脑膜瘤的生存分布相似。在 I 级脑膜瘤中,Ki-67/MIB-1 指数和辛普森分级都是复发的独立预测因素。对于 Ki-67/MIB-1≥3%的 I 级脑膜瘤和 II 级脑膜瘤,应采用类似的管理方案。

相似文献

1
Value of KI-67/MIB-1 labeling index and simpson grading system to predict the recurrence of who grade I intracranial meningiomas compared to who grade II.KI-67/MIB-1 标记指数和辛普森分级系统对预测 WHO 分级 I 颅内脑膜瘤与 WHO 分级 II 相比的复发价值。
J Clin Neurosci. 2021 Apr;86:32-37. doi: 10.1016/j.jocn.2021.01.009. Epub 2021 Jan 26.
2
Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.辛普森分级系统在现代脑膜瘤手术中的意义:将分级与 MIB-1 标记指数相结合,作为预测 WHO Ⅰ级脑膜瘤复发的关键。
J Neurosurg. 2012 Jul;117(1):121-8. doi: 10.3171/2012.3.JNS111945. Epub 2012 May 4.
3
Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.Ki-67 指数作为脑膜瘤切除术后复发的预测标志物。
J Clin Neurosci. 2024 Jun;124:15-19. doi: 10.1016/j.jocn.2024.04.015. Epub 2024 Apr 16.
4
[Relevance of Simpson's grading system for resections in WHO grade I meningiomas].[辛普森分级系统对世界卫生组织I级脑膜瘤切除术的相关性]
Neurocirugia (Astur). 2017 Jul-Aug;28(4):176-182. doi: 10.1016/j.neucir.2016.12.001. Epub 2017 Feb 24.
5
Resected WHO grade I meningioma and predictors of local control.切除的世界卫生组织一级脑膜瘤及局部控制的预测因素。
J Neurooncol. 2021 Mar;152(1):145-151. doi: 10.1007/s11060-020-03688-1. Epub 2021 Jan 9.
6
The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas.Simpson 分级 I 和 II 切除术在现代神经外科治疗世界卫生组织分级 I 脑膜瘤中的相关性。
J Neurosurg. 2010 Nov;113(5):1029-35. doi: 10.3171/2010.3.JNS091971. Epub 2010 Apr 9.
7
The Simpson grading revisited: aggressive surgery and its place in modern meningioma management.辛普森分级再探讨:积极手术及其在现代脑膜瘤管理中的地位。
J Neurosurg. 2016 Sep;125(3):551-60. doi: 10.3171/2015.9.JNS15754. Epub 2016 Jan 29.
8
The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?脑膜瘤手术中的辛普森分级:肿瘤位置会影响其预后价值吗?
J Neurooncol. 2017 Jul;133(3):641-651. doi: 10.1007/s11060-017-2481-1. Epub 2017 May 19.
9
Effect of dural detachment on long-term tumor control for meningiomas treated using Simpson grade IV resection.硬脑膜剥离对 Simpson 分级 IV 切除治疗脑膜瘤的长期肿瘤控制效果的影响。
J Neurosurg. 2013 Dec;119(6):1373-9. doi: 10.3171/2013.8.JNS13832. Epub 2013 Sep 20.
10
The Relevance of Simpson Grade Resections in Modern Neurosurgical Treatment of World Health Organization Grade I, II, and III Meningiomas.辛普森分级切除在世界卫生组织I级、II级和III级脑膜瘤现代神经外科治疗中的相关性
World Neurosurg. 2018 Jan;109:e588-e593. doi: 10.1016/j.wneu.2017.10.028. Epub 2017 Oct 16.

引用本文的文献

1
Prognostic value of MIB-1 index in meningioma: a retrospective cohort study to establish an optimal cutoff for recurrence and survival.MIB-1指数在脑膜瘤中的预后价值:一项回顾性队列研究以确定复发和生存的最佳临界值
J Neurooncol. 2025 May 12. doi: 10.1007/s11060-025-05057-2.
2
Development of a Machine Learning Algorithm for the Prediction of WHO Grade 1 Meningioma Recurrence.用于预测世界卫生组织1级脑膜瘤复发的机器学习算法的开发
Cureus. 2025 Apr 10;17(4):e82033. doi: 10.7759/cureus.82033. eCollection 2025 Apr.
3
Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
用于预测脑膜瘤患者预后的生物标志物:系统评价和荟萃分析。
PLoS One. 2024 May 17;19(5):e0303337. doi: 10.1371/journal.pone.0303337. eCollection 2024.
4
Predictor factors for recurrence in atypical meningiomas.非典型脑膜瘤复发的预测因素。
Rom J Morphol Embryol. 2023 Jul-Sep;64(3):333-342. doi: 10.47162/RJME.64.3.05.
5
The evaluation of tumorigenicity and characterization of colonies in a soft agar colony formation assay using polymerase chain reaction.采用聚合酶链反应的软琼脂集落形成试验中肿瘤形成能力的评估和集落特征分析。
Sci Rep. 2023 Apr 3;13(1):5405. doi: 10.1038/s41598-023-32442-6.
6
A High MCM6 Proliferative Index in Atypical Meningioma Is Associated with Shorter Progression Free and Overall Survivals.非典型脑膜瘤中高MCM6增殖指数与较短的无进展生存期和总生存期相关。
Cancers (Basel). 2023 Jan 16;15(2):535. doi: 10.3390/cancers15020535.
7
Matched case-control analysis of outcomes following surgical resection of incidental meningioma.偶然脑膜瘤切除术后结局的配对病例对照分析。
J Neurooncol. 2022 Nov;160(2):481-489. doi: 10.1007/s11060-022-04167-5. Epub 2022 Nov 3.